0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global ANXA5 Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-18M2001
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global ANXA5 Market Insights and Forecast to 2028
BUY CHAPTERS

Global ANXA5 Market Research Report 2025

Code: QYRE-Auto-18M2001
Report
January 2025
Pages:75
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

ANXA5 Market

The global market for ANXA5 was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
ANXA5 (Annexin A5) is a Protein Coding gene. Diseases associated with ANXA5 include Pregnancy Loss, Recurrent 3 and Antiphospholipid Syndrome. Among its related pathways are Response to elevated platelet cytosolic Ca2+ and Regulation of CFTR activity (norm and CF). Gene Ontology (GO) annotations related to this gene include calcium ion binding and calcium-dependent phospholipid binding. An important paralog of this gene is ANXA4.
In terms of regions, North America is expected to remain the largest market during the forecast period.
This report aims to provide a comprehensive presentation of the global market for ANXA5, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ANXA5.
The ANXA5 market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global ANXA5 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ANXA5 companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of ANXA5 Market Report

Report Metric Details
Report Name ANXA5 Market
Segment by Type
  • Above 90%
  • Above 95%
  • Above 99%
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bio-Rad, Thermo Fisher Scientific, R&D Systems, Lifespan Biosciences, Genetex, Atlas Antibodies, Abbexa Ltd, BioLegend, USBiological
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of ANXA5 company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the ANXA5 Market report?

Ans: The main players in the ANXA5 Market are Bio-Rad, Thermo Fisher Scientific, R&D Systems, Lifespan Biosciences, Genetex, Atlas Antibodies, Abbexa Ltd, BioLegend, USBiological

What are the Application segmentation covered in the ANXA5 Market report?

Ans: The Applications covered in the ANXA5 Market report are Biopharmaceutical Companies, Bioscience Research Institutions, Others

What are the Type segmentation covered in the ANXA5 Market report?

Ans: The Types covered in the ANXA5 Market report are Above 90%, Above 95%, Above 99%, Others

Recommended Reports

Therapeutics & Disease Treatment

Genomics & Molecular Medicine

Pharmaceutical Components & Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ANXA5 Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Above 90%
1.2.3 Above 95%
1.2.4 Above 99%
1.2.5 Others
1.3 Market by Application
1.3.1 Global ANXA5 Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biopharmaceutical Companies
1.3.3 Bioscience Research Institutions
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global ANXA5 Market Perspective (2020-2031)
2.2 Global ANXA5 Growth Trends by Region
2.2.1 Global ANXA5 Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 ANXA5 Historic Market Size by Region (2020-2025)
2.2.3 ANXA5 Forecasted Market Size by Region (2026-2031)
2.3 ANXA5 Market Dynamics
2.3.1 ANXA5 Industry Trends
2.3.2 ANXA5 Market Drivers
2.3.3 ANXA5 Market Challenges
2.3.4 ANXA5 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ANXA5 Players by Revenue
3.1.1 Global Top ANXA5 Players by Revenue (2020-2025)
3.1.2 Global ANXA5 Revenue Market Share by Players (2020-2025)
3.2 Global ANXA5 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by ANXA5 Revenue
3.4 Global ANXA5 Market Concentration Ratio
3.4.1 Global ANXA5 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ANXA5 Revenue in 2024
3.5 Global Key Players of ANXA5 Head office and Area Served
3.6 Global Key Players of ANXA5, Product and Application
3.7 Global Key Players of ANXA5, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 ANXA5 Breakdown Data by Type
4.1 Global ANXA5 Historic Market Size by Type (2020-2025)
4.2 Global ANXA5 Forecasted Market Size by Type (2026-2031)
5 ANXA5 Breakdown Data by Application
5.1 Global ANXA5 Historic Market Size by Application (2020-2025)
5.2 Global ANXA5 Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America ANXA5 Market Size (2020-2031)
6.2 North America ANXA5 Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America ANXA5 Market Size by Country (2020-2025)
6.4 North America ANXA5 Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ANXA5 Market Size (2020-2031)
7.2 Europe ANXA5 Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe ANXA5 Market Size by Country (2020-2025)
7.4 Europe ANXA5 Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ANXA5 Market Size (2020-2031)
8.2 Asia-Pacific ANXA5 Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific ANXA5 Market Size by Region (2020-2025)
8.4 Asia-Pacific ANXA5 Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ANXA5 Market Size (2020-2031)
9.2 Latin America ANXA5 Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America ANXA5 Market Size by Country (2020-2025)
9.4 Latin America ANXA5 Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ANXA5 Market Size (2020-2031)
10.2 Middle East & Africa ANXA5 Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa ANXA5 Market Size by Country (2020-2025)
10.4 Middle East & Africa ANXA5 Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio-Rad
11.1.1 Bio-Rad Company Details
11.1.2 Bio-Rad Business Overview
11.1.3 Bio-Rad ANXA5 Introduction
11.1.4 Bio-Rad Revenue in ANXA5 Business (2020-2025)
11.1.5 Bio-Rad Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific ANXA5 Introduction
11.2.4 Thermo Fisher Scientific Revenue in ANXA5 Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 R&D Systems
11.3.1 R&D Systems Company Details
11.3.2 R&D Systems Business Overview
11.3.3 R&D Systems ANXA5 Introduction
11.3.4 R&D Systems Revenue in ANXA5 Business (2020-2025)
11.3.5 R&D Systems Recent Development
11.4 Lifespan Biosciences
11.4.1 Lifespan Biosciences Company Details
11.4.2 Lifespan Biosciences Business Overview
11.4.3 Lifespan Biosciences ANXA5 Introduction
11.4.4 Lifespan Biosciences Revenue in ANXA5 Business (2020-2025)
11.4.5 Lifespan Biosciences Recent Development
11.5 Genetex
11.5.1 Genetex Company Details
11.5.2 Genetex Business Overview
11.5.3 Genetex ANXA5 Introduction
11.5.4 Genetex Revenue in ANXA5 Business (2020-2025)
11.5.5 Genetex Recent Development
11.6 Atlas Antibodies
11.6.1 Atlas Antibodies Company Details
11.6.2 Atlas Antibodies Business Overview
11.6.3 Atlas Antibodies ANXA5 Introduction
11.6.4 Atlas Antibodies Revenue in ANXA5 Business (2020-2025)
11.6.5 Atlas Antibodies Recent Development
11.7 Abbexa Ltd
11.7.1 Abbexa Ltd Company Details
11.7.2 Abbexa Ltd Business Overview
11.7.3 Abbexa Ltd ANXA5 Introduction
11.7.4 Abbexa Ltd Revenue in ANXA5 Business (2020-2025)
11.7.5 Abbexa Ltd Recent Development
11.8 BioLegend
11.8.1 BioLegend Company Details
11.8.2 BioLegend Business Overview
11.8.3 BioLegend ANXA5 Introduction
11.8.4 BioLegend Revenue in ANXA5 Business (2020-2025)
11.8.5 BioLegend Recent Development
11.9 USBiological
11.9.1 USBiological Company Details
11.9.2 USBiological Business Overview
11.9.3 USBiological ANXA5 Introduction
11.9.4 USBiological Revenue in ANXA5 Business (2020-2025)
11.9.5 USBiological Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global ANXA5 Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Above 90%
 Table 3. Key Players of Above 95%
 Table 4. Key Players of Above 99%
 Table 5. Key Players of Others
 Table 6. Global ANXA5 Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global ANXA5 Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global ANXA5 Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global ANXA5 Market Share by Region (2020-2025)
 Table 10. Global ANXA5 Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global ANXA5 Market Share by Region (2026-2031)
 Table 12. ANXA5 Market Trends
 Table 13. ANXA5 Market Drivers
 Table 14. ANXA5 Market Challenges
 Table 15. ANXA5 Market Restraints
 Table 16. Global ANXA5 Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global ANXA5 Market Share by Players (2020-2025)
 Table 18. Global Top ANXA5 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ANXA5 as of 2024)
 Table 19. Ranking of Global Top ANXA5 Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by ANXA5 Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of ANXA5, Headquarters and Area Served
 Table 22. Global Key Players of ANXA5, Product and Application
 Table 23. Global Key Players of ANXA5, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global ANXA5 Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global ANXA5 Revenue Market Share by Type (2020-2025)
 Table 27. Global ANXA5 Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global ANXA5 Revenue Market Share by Type (2026-2031)
 Table 29. Global ANXA5 Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global ANXA5 Revenue Market Share by Application (2020-2025)
 Table 31. Global ANXA5 Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global ANXA5 Revenue Market Share by Application (2026-2031)
 Table 33. North America ANXA5 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America ANXA5 Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America ANXA5 Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe ANXA5 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe ANXA5 Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe ANXA5 Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific ANXA5 Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific ANXA5 Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific ANXA5 Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America ANXA5 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America ANXA5 Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America ANXA5 Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa ANXA5 Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa ANXA5 Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa ANXA5 Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Bio-Rad Company Details
 Table 49. Bio-Rad Business Overview
 Table 50. Bio-Rad ANXA5 Product
 Table 51. Bio-Rad Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 52. Bio-Rad Recent Development
 Table 53. Thermo Fisher Scientific Company Details
 Table 54. Thermo Fisher Scientific Business Overview
 Table 55. Thermo Fisher Scientific ANXA5 Product
 Table 56. Thermo Fisher Scientific Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 57. Thermo Fisher Scientific Recent Development
 Table 58. R&D Systems Company Details
 Table 59. R&D Systems Business Overview
 Table 60. R&D Systems ANXA5 Product
 Table 61. R&D Systems Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 62. R&D Systems Recent Development
 Table 63. Lifespan Biosciences Company Details
 Table 64. Lifespan Biosciences Business Overview
 Table 65. Lifespan Biosciences ANXA5 Product
 Table 66. Lifespan Biosciences Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 67. Lifespan Biosciences Recent Development
 Table 68. Genetex Company Details
 Table 69. Genetex Business Overview
 Table 70. Genetex ANXA5 Product
 Table 71. Genetex Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 72. Genetex Recent Development
 Table 73. Atlas Antibodies Company Details
 Table 74. Atlas Antibodies Business Overview
 Table 75. Atlas Antibodies ANXA5 Product
 Table 76. Atlas Antibodies Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 77. Atlas Antibodies Recent Development
 Table 78. Abbexa Ltd Company Details
 Table 79. Abbexa Ltd Business Overview
 Table 80. Abbexa Ltd ANXA5 Product
 Table 81. Abbexa Ltd Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 82. Abbexa Ltd Recent Development
 Table 83. BioLegend Company Details
 Table 84. BioLegend Business Overview
 Table 85. BioLegend ANXA5 Product
 Table 86. BioLegend Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 87. BioLegend Recent Development
 Table 88. USBiological Company Details
 Table 89. USBiological Business Overview
 Table 90. USBiological ANXA5 Product
 Table 91. USBiological Revenue in ANXA5 Business (2020-2025) & (US$ Million)
 Table 92. USBiological Recent Development
 Table 93. Research Programs/Design for This Report
 Table 94. Key Data Information from Secondary Sources
 Table 95. Key Data Information from Primary Sources
 Table 96. Authors List of This Report


List of Figures
 Figure 1. ANXA5 Picture
 Figure 2. Global ANXA5 Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global ANXA5 Market Share by Type: 2024 VS 2031
 Figure 4. Above 90% Features
 Figure 5. Above 95% Features
 Figure 6. Above 99% Features
 Figure 7. Others Features
 Figure 8. Global ANXA5 Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global ANXA5 Market Share by Application: 2024 VS 2031
 Figure 10. Biopharmaceutical Companies Case Studies
 Figure 11. Bioscience Research Institutions Case Studies
 Figure 12. Others Case Studies
 Figure 13. ANXA5 Report Years Considered
 Figure 14. Global ANXA5 Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global ANXA5 Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global ANXA5 Market Share by Region: 2024 VS 2031
 Figure 17. Global ANXA5 Market Share by Players in 2024
 Figure 18. Global Top ANXA5 Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ANXA5 as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by ANXA5 Revenue in 2024
 Figure 20. North America ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America ANXA5 Market Share by Country (2020-2031)
 Figure 22. United States ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe ANXA5 Market Share by Country (2020-2031)
 Figure 26. Germany ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific ANXA5 Market Share by Region (2020-2031)
 Figure 34. China ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America ANXA5 Market Share by Country (2020-2031)
 Figure 42. Mexico ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa ANXA5 Market Share by Country (2020-2031)
 Figure 46. Turkey ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE ANXA5 Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Bio-Rad Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 50. Thermo Fisher Scientific Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 51. R&D Systems Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 52. Lifespan Biosciences Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 53. Genetex Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 54. Atlas Antibodies Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 55. Abbexa Ltd Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 56. BioLegend Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 57. USBiological Revenue Growth Rate in ANXA5 Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI